Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HIMX
HIMX logo

HIMX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Himax Technologies Inc (HIMX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
8.590
1 Day change
-4.45%
52 Week Range
12.000
Analysis Updated At
2026/03/20
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Himax Technologies Inc (HIMX) is not a strong buy at this time for a beginner investor with a long-term strategy. The lack of significant positive catalysts, weak financial performance, and neutral trading sentiment suggest that holding off on investment would be prudent.

Technical Analysis

The MACD is positive but contracting, RSI is neutral at 54.389, and moving averages are converging, indicating no clear trend. Support and resistance levels show a pivot at 9.377, with resistance at 11.207 and support at 7.548. The stock is trading below the pivot level, suggesting weakness.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
8

Positive Catalysts

  • Himax was confirmed as the sole microlens array supplier for Nvidia and potentially a primary supplier for Apple's upcoming smart glasses, leading to an 11% stock surge recently.

Neutral/Negative Catalysts

  • Morgan Stanley downgraded the stock to Equal Weight due to weaker demand in key markets, gross margin pressure, and lack of new growth drivers. Financial performance in Q4 2025 showed significant declines in revenue (-14.39% YoY), net income (-74.25% YoY), and EPS (-71.43% YoY).

Financial Performance

In Q4 2025, revenue dropped to $203.08M (-14.39% YoY), net income fell to $6.34M (-74.25% YoY), and EPS declined to $0.02 (-71.43% YoY). Gross margin slightly decreased to 30.38% (-0.26% YoY), indicating weak financial health.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Morgan Stanley downgraded the stock to Equal Weight from Overweight, maintaining a price target of $8. The downgrade cites weaker demand in computers, smartphones, and autos, along with rising memory costs and lack of growth drivers.

Wall Street analysts forecast HIMX stock price to rise
1 Analyst Rating
Wall Street analysts forecast HIMX stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 8.990
sliders
Low
10
Averages
10
High
10
Current: 8.990
sliders
Low
10
Averages
10
High
10
Morgan Stanley
Overweight -> Equal Weight
downgrade
$8
AI Analysis
2026-02-04
Reason
Morgan Stanley
Price Target
$8
AI Analysis
2026-02-04
downgrade
Overweight -> Equal Weight
Reason
Morgan Stanley downgraded Himax to Equal Weight from Overweight with an unchanged price target of $8. The firm says weaker computer, smartphone and auto demand, in addition to gross margin pressure and a lack of new growth drivers will weigh on the display driver integrated circuit vendors. Rising memory costs will add to the headwinds, driving further downside in PCs, smartphones and autos, the analyst tells investors in a research note.
Morgan Stanley
Overweight
initiated
$8.80
2025-05-09
Reason
Morgan Stanley
Price Target
$8.80
2025-05-09
initiated
Overweight
Reason
Morgan Stanley initiated coverage of Himax with an Overweight rating and $8.80 price target. Himax is expanding its non-driver integrated circuit business by tapping the growing cloud AI and edge AI markets, the analyst tells investors in a research note. The firm says this bodes well for the company's growth and margin expansion. It expects rising OLED penetration in LDDI and autos to drive Himax's sales growth.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HIMX
Unlock Now

People Also Watch